Pharmaniaga's financials are still messy with that massive PN17 hit, and until their balance sheet clears up, the fundamentals remain very shaky for long-term holding. 18-19 cents is just a psychological resistance; until they actually show sustainable profit growth, better to wait on the sidelines.